Lymphocele disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: LYM005 MIFTS: 38	Lymphocele Categories: Immune diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Lymphocele

MalaCards integrated aliases for Lymphocele:

Name: Lymphocele ¹² ⁴⁵ ¹⁵ ⁷⁴

Lymphocele Adverse Event ⁷⁴

Lymph Cyst ¹²

Classifications:

MalaCards categories:
Anatomical: Immune diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:4347

MeSH ⁴⁵ D008210

NCIt ⁵¹ C78442

SNOMED-CT ⁶⁹ 12167004

UMLS ⁷⁴ C0024248 C1963162

Sources

Summaries for Lymphocele

MalaCards based summary : Lymphocele, also known as lymphocele adverse event, is related to campomelia, cumming type and ovarian cancer. An important gene associated with Lymphocele is KLK3 (Kallikrein Related Peptidase 3), and among its related pathways/superpathways is NFAT and Cardiac Hypertrophy. The drugs Everolimus and tannic acid have been mentioned in the context of this disorder. Affiliated tissues include kidney, lymph node and breast, and related phenotypes are Decreased viability and Decreased viability

Wikipedia : ⁷⁷ A lymphocele is a collection of lymphatic fluid within the body not bordered by epithelial lining. It... more...

Sources

Related Diseases for Lymphocele

Diseases related to Lymphocele via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 35)

#	Related Disease	Score	Top Affiliating Genes
1	campomelia, cumming type	12.1
2	ovarian cancer	10.2
3	prostate cancer	10.2
4	prostate cancer, hereditary, 8	10.2
5	prostate cancer, hereditary, 6	10.2
6	melanoma	10.1
7	ascites, chylous	10.0
8	cervical cancer	10.0
9	breast reconstruction	10.0
10	lymphedema	10.0
11	thrombosis	10.0
12	cardiogenic shock	10.0
13	radiation cystitis	9.9	KLK3 MAPK8IP1
14	breast cancer	9.9
15	diaphragmatic hernia, congenital	9.9
16	suppressor of tumorigenicity 3	9.9
17	endometrial cancer	9.9
18	arteriovenous fistula	9.9
19	nephrolithiasis	9.9
20	lymphoma	9.9
21	scoliosis	9.9
22	polycystic kidney disease	9.9
23	filariasis	9.9
24	sarcoma	9.9
25	filarial elephantiasis	9.9
26	cystadenoma	9.9
27	anuria	9.9
28	testicular cancer	9.9
29	skin carcinoma	9.9
30	ureteral obstruction	9.9
31	kidney disease	9.9
32	pulmonary embolism	9.9
33	reproductive system disease	9.8	KLK3 MAPK8IP1
34	urinary system disease	9.7	CABIN1 KLK3 MTOR
35	hydronephrosis	9.7

Graphical network of the top 20 diseases related to Lymphocele:

Sources

Symptoms & Phenotypes for Lymphocele

GenomeRNAi Phenotypes related to Lymphocele according to GeneCards Suite gene sharing:

²⁷ (show all 11)

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased viability	GR00055-A-2	9.5	MTOR
2	Decreased viability	GR00173-A	9.5	MAPK8IP1
3	Decreased viability	GR00221-A-1	9.5	MTOR
4	Decreased viability	GR00221-A-3	9.5	RASA1
5	Decreased viability	GR00221-A-4	9.5	MAPK8IP1 MTOR RASA1
6	Decreased viability	GR00301-A	9.5	MAPK8IP1
7	Decreased viability	GR00342-S-1	9.5	MTOR
8	Decreased viability	GR00342-S-2	9.5	MTOR
9	Decreased viability	GR00342-S-3	9.5	MAPK8IP1
10	Decreased viability	GR00381-A-1	9.5	RASA1
11	Decreased viability	GR00402-S-2	9.5	MAPK8IP1 MTOR RASA1

MGI Mouse Phenotypes related to Lymphocele:

⁴⁷

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	mortality/aging	MP:0010768	9.1	ANKRD11 CABIN1 MAPK8IP1 MTOR PCSK7 RASA1

Sources

Drugs & Therapeutics for Lymphocele

Drugs for Lymphocele (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 81)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Everolimus

Approved

Phase 4,Phase 3,Phase 1,Early Phase 1

159351-69-6

6442177 70789204

tannic acid

Approved

Phase 4,Phase 1,Early Phase 1

1401-55-4

Benzocaine

Approved, Investigational

Phase 4,Phase 1,Early Phase 1

94-09-7, 1994-09-7

2337

Mycophenolic acid

Approved

Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1

24280-93-1

446541

Miconazole

Approved, Investigational, Vet_approved

Phase 4,Phase 3,Phase 1,Early Phase 1

22916-47-8

4189

Sirolimus

Approved, Investigational

Phase 4,Phase 3,Phase 1,Early Phase 1

53123-88-9

46835353 6436030 5284616

Tacrolimus

Approved, Investigational

Phase 4,Phase 2,Phase 3,Early Phase 1

104987-11-3

445643 439492 6473866

Prednisone

Approved, Vet_approved

Phase 4,Phase 1

53-03-2

5865

Methylprednisolone

Approved, Vet_approved

Phase 4,Phase 2,Phase 3

83-43-2

6741

Methylprednisolone hemisuccinate

Approved

Phase 4,Phase 2,Phase 3

2921-57-5

Prednisolone phosphate

Approved, Vet_approved

Phase 4,Phase 2,Phase 3

302-25-0

Basiliximab

Approved, Investigational

Phase 4,Phase 3

152923-56-3, 179045-86-4

Prednisolone

Approved, Vet_approved

Phase 4,Phase 2,Phase 3

50-24-8

5755

Triamcinolone

Approved, Vet_approved

Phase 4,Phase 3

124-94-7

31307

Heparin

Approved, Investigational

Phase 4

9005-49-6

772 46507594

Calcium

Approved, Nutraceutical

Phase 4

7440-70-2

271

Prednisolone hemisuccinate

Experimental

Phase 4,Phase 2,Phase 3

2920-86-7

Hemostatics

Phase 4,Phase 3,Not Applicable

Coagulants

Phase 4,Phase 3,Not Applicable

Antilymphocyte Serum

Phase 4,Early Phase 1

Calcineurin Inhibitors

Phase 4,Phase 3,Early Phase 1

Antifungal Agents

Phase 4,Phase 3,Phase 1,Early Phase 1

Immunologic Factors

Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1

Antibiotics, Antitubercular

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1

Antitubercular Agents

Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1

Thymoglobulin

Phase 4,Phase 2,Phase 3,Early Phase 1

Anti-Bacterial Agents

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1

Anti-Infective Agents

Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1

Anesthetics

Phase 4

Immunosuppressive Agents

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1

Antirheumatic Agents

Phase 4,Phase 3,Phase 1,Early Phase 1

Hormones, Hormone Substitutes, and Hormone Antagonists

Phase 4,Phase 3,Phase 2,Phase 1

glucocorticoids

Phase 4,Phase 2,Phase 3,Phase 1

Dermatologic Agents

Phase 4,Phase 3

Cyclosporins

Phase 4,Phase 3

Antineoplastic Agents, Hormonal

Phase 4,Phase 1,Not Applicable

Hormone Antagonists

Phase 4,Phase 3,Phase 2,Phase 1

Anti-Inflammatory Agents

Phase 4,Phase 2,Phase 3,Phase 1

Hormones

Phase 4,Phase 3,Phase 2,Phase 1

Autonomic Agents

Phase 4,Phase 2,Phase 3

Prednisolone acetate

Phase 4,Phase 2,Phase 3

Peripheral Nervous System Agents

Phase 4,Phase 2,Phase 3

Methylprednisolone Acetate

Phase 4,Phase 2,Phase 3

Antiemetics

Phase 4,Phase 2,Phase 3

Neuroprotective Agents

Phase 4,Phase 2,Phase 3

Protective Agents

Phase 4,Phase 2,Phase 3

Gastrointestinal Agents

Phase 4,Phase 2,Phase 3,Not Applicable

triamcinolone acetonide

Phase 4,Phase 3

Triamcinolone diacetate

Phase 4,Phase 3

Triamcinolone hexacetonide

Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 55)

#	Name	Status	NCT ID	Phase	Drugs
1	Application of Tachosil During Lymphadenectomy	Completed	NCT03752606	Phase 4
2	A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection	Completed	NCT02476357	Phase 4
3	Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.	Completed	NCT02001857	Phase 4	1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.
4	Clinical Trial of a Silver Eluting Dressing System	Completed	NCT01229358	Phase 4
5	Improved Induction and Maintenance Immunosuppression in Kidney Transplantation	Completed	NCT00556933	Phase 4	rabbit anti-thymocyte globulin;mycophenolate mofetil;rabbit anti-thymocyte globulin;sirolimus;tacrolimus
6	Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation	Completed	NCT00305396	Phase 4	Sirolimus
7	SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus	Completed	NCT00371826	Phase 4	Everolimus (RAD001);Cyclosporine (Calcineurin Inhibitor (CNI));Methylprednisone/prednisone;Mycophenolate sodium (MPA)
8	Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A	Completed	NCT02328963	Phase 4	Everolimus;mycophenolic acid
9	MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients	Completed	NCT00231764	Phase 4	daclizumab
10	PREvention of VENous ThromboEmbolism Following Radical Prostatectomy	Recruiting	NCT03006562	Phase 4	Subcutaneous Heparin
11	Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy	Terminated	NCT01365143	Phase 4
12	Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer	Unknown status	NCT01974193	Phase 3	Floseal
13	Tachosil for the Prevention of Symptomatic Lymph Cysts	Completed	NCT01470677	Phase 3	Tachosil fibrin patch
14	Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer	Completed	NCT00630695	Phase 3	Lanreotide LP 90;Placebo lanreotide
15	Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplantation	Completed	NCT01631448	Phase 3
16	Myfortic vs. Cellcept in Kidney Transplant Recipients	Completed	NCT00533624	Phase 2, Phase 3	Mycophenolate Sodium Delayed Release Tablets;Mycophenolate Mofetil
17	12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients	Completed	NCT01843348	Phase 3	Everolimus;Tacrolimus;Cyclosporin A;Enteric Coated Mycophenolate Sodium (EC-MPS);Mycophenolate mofetil (MMF);Corticosteroids;Simulect
18	A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer	Recruiting	NCT03071289	Phase 3	Cisplatin
19	Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm	Active, not recruiting	NCT01461850	Phase 3	Neoadjuvant chemotherapy + Interval Debulking Surgery
20	Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer	Completed	NCT01356862	Phase 2	PASIREOTIDE;PLACEBO
21	Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer	Recruiting	NCT02125513	Phase 2	carboplatin and paclitaxel followed by surgery
22	Tolerance by Engaging Antigen During Cellular Homeostasis	Recruiting	NCT03504241	Phase 1	alemtuzumab;belatacept;sirolimus;mycophenolate mofetil;mycophenolate acid;prednisone
23	PREvention of Post-mastectomy LYMphoceles by PAdding	Unknown status	NCT02894021	Not Applicable
24	Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer	Unknown status	NCT01717794	Not Applicable
25	Lymphedema After Primary Surgery for Endometrial Cancer	Unknown status	NCT02115477
26	Thunderbeat Technology vs Standard Bipolar Electro Surgery in Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy for Cervical Cancer	Unknown status	NCT01717781	Not Applicable
27	Cold Plasma for the Reduction of Lymphoceles Following PLND	Completed	NCT02658851	Not Applicable
28	Prevention of Lymphoceles After Robotic PLND	Completed	NCT02035475	Not Applicable
29	Prophylactic Fenestration of the Peritoneum in Kidney Transplantation	Completed	NCT01206868	Not Applicable
30	Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer	Completed	NCT01679483	Not Applicable	FloSeal application
31	Efficacy Study of Ifabond in Breast Cancer Surgery	Completed	NCT01742975	Not Applicable
32	The Comparison of Conventional and Advanced Bipolar Energy Modalities During Laparoscopic Staging Surgery of Gynecologic Cancers	Completed	NCT02822820	Not Applicable
33	Fibrin Sealant in Renal Transplantation	Completed	NCT00910052	Not Applicable
34	2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial	Completed	NCT02320578	Not Applicable
35	2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial	Completed	NCT02320565	Not Applicable
36	Dead Space Closure With Quilting Suture Versus Conventional Closure With Drainage	Completed	NCT02263651	Not Applicable
37	Sentinel Lymph Node Detection in Endometrial Cancer	Completed	NCT02690259	Not Applicable
38	Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency	Completed	NCT02588911	Not Applicable
39	Management of Symptomatic Post-operative Lymphocele	Recruiting	NCT02800980
40	Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection	Recruiting	NCT03765320
41	The AbsorbaSeal Vascular Closure Device Trial	Recruiting	NCT03730571	Not Applicable
42	Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers	Recruiting	NCT02986568	Not Applicable	Cisplatin;Cisplatin;5-fluorouracil, Cisplatin;5-fluorouracil, Cisplatin;Doxorubicin, Cisplatin
43	ADNEXMR Scoring System: Impact of an MR Scoring System on Therapeutic Strategy of Pelvic Adnexal Masses	Recruiting	NCT02664597	Not Applicable
44	Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer	Recruiting	NCT02494063
45	Use of the Sentinel Node Biopsy for Early Endometrial Cancer.	Recruiting	NCT02545348
46	Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique	Recruiting	NCT02687308	Not Applicable
47	Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy	Not yet recruiting	NCT03567525	Not Applicable
48	Preventive Fenestration With and Without Clipping in Kidney Transplantation	Not yet recruiting	NCT03682627	Not Applicable
49	Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery	Not yet recruiting	NCT03772821
50	Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma	Not yet recruiting	NCT03716414

Search NIH Clinical Center for Lymphocele

Cochrane evidence based reviews: lymphocele

Sources

Genetic Tests for Lymphocele

Sources

Anatomical Context for Lymphocele

MalaCards organs/tissues related to Lymphocele:

⁴²

Kidney, Lymph Node, Breast, Prostate, Liver, Pancreas, Heart

Sources

Publications for Lymphocele

Articles related to Lymphocele:

(show top 50) (show all 357)

#	Title	Authors	Year
1	The application of fibrin sealant for the prevention of lymphocele after lymphadenectomy in patients with gynecological malignancies: A systematic review and meta-analysis of randomized controlled trials. ( 30660344 )	Prodromidou A...Kalinoglou N	2019
2	Lymphatic supermicrosurgery for the treatment of recurrent lymphocele and severe lymphorrhea. ( 30767257 )	Giacalone G...Koshima I	2019
3	Reduction of lymphocele rate in patients undergoing sentinel node biopsy for melanoma by intraoperative placement of plant-based hemostatic powder: Results of a prospective trial. ( 30799018 )	Luong J...Vetto JT	2019
4	Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy. ( 30910151 )	Weinberger V...Zikan M	2019
5	Treatment of refractory groin lymphocele by surrounding supermicrosurgical lymphaticovenous anastomosis. ( 29788678 )	Ayestaray B....Picquot S.	2018
6	Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer. ( 29775698 )	Buelens S....Lumen N.	2018
7	Robotic prostatectomy leading to a delayed MRSA infected lymphocele: a case report and review of the literature. ( 29344094 )	Kaminski M....Siegel S.	2018
8	An unusual localization of seven months delayed pelvic lymphocele following radical retropubic prostatectomy: Case report and literature review. ( 29524857 )	HazA+r B....AkdoA9an B.	2018
9	Functional significance and risk factors for lymphocele formation after renal transplantation. ( 29864262 )	Heer M.K....Hibberd A.D.	2018
10	Transinguinal interstitial (intranodal) lymphatic embolization to treat high-output postoperative lymphocele. ( 29551619 )	Srinivasa R.N....Srinivasa R.N.	2018
11	Doxycycline sclerotherapy for post-traumatic inguinal lymphocele in a child. ( 29367372 )	Harrington A.W....Cowles R.A.	2018
12	Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery. ( 29599346 )	Perrin M....Gouy S.	2018
13	Regarding &quot;Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients&quot;. ( 29579476 )	Srinivasa R.N....Chick J.F.B.	2018
14	Comparison Between Bipolar Lymphatic Vessels Cautery and Suture Ligature in Prevention of Postrenal Transplant Lymphocele Formation: A Randomized Controlled Trial. ( 29697354 )	Simforoosh N....Gholamrezaie H.R.	2018
15	Embolization-sclerotherapy of a refractory large volume post-operative pelvic lymphocele. ( 29988753 )	Addo E...El-Haddad G	2018
16	Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial. ( 30099769 )	Burghuber CK...Berlakovich GA	2018
17	The role of pelvic lymphocele in the development of early postoperative complications. ( 30212991 )	Neagoe OC...Mazilu O	2018
18	Intranodal Glue Embolization for the Management of Postsurgical Groin Lymphocele and Lymphorrhea. ( 30217746 )	Smolock AR...Itkin M	2018
19	Efficacy of a Fibrin Sealant (Tissucol Duo) for the Preventionof Lymphocele after Laparoscopic Pelvic Lymphadenectomy:A Randomized Controlled Trial. ( 30296475 )	Jaunarena I...Lekuona A	2018
20	Abdominal Lymphocele Following Anterior Lumbar Interbody Fusion: A Case Report. ( 30510867 )	Hazama A...Chin LS	2018
21	Indocyanine green-enhanced fluorescence-guided video-assisted axillary surgery for chronic lymphocele. ( 30549254 )	Mazza M...Sommariva A	2018
22	Colloid Osmotic Pressure Participates on the Post-transplant Lymphocele Pathogenesis. ( 30577216 )	Pacovsky J...Brodak M	2018
23	TEMPORARY REMOVAL: P.L.E.A.T. - Preventing Lymphocele Ensuring Absorption Transperitoneally: a novel robotic technique. ( 28554519 )	Moro F.D....Zattoni F.	2017
24	Microbiological evaluation of infected pelvic lymphocele after robotic prostatectomy: potential predictors for culture positivity and selection of the best empirical antimicrobial therapy. ( 28439680 )	Hamada A....Tuerk I.	2017
25	Delayed Infection of a Lymphocele following RARP in a Patient with Nonspecific Symptoms. ( 28396817 )	Taniguchi T....Ishida K.	2017
26	Rate of Symptomatic Lymphocele Formation After Extraperitoneal vs Transperitoneal Robot-Assisted Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy. ( 28741376 )	Horovitz D....Joseph J.V.	2017
27	Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection. ( 28989920 )	Yoo B....Kim Y.B.	2017
28	Treatment of Post-transplant Lymphocele in Children. ( 28132852 )	Gander R....Ariceta G.	2017
29	Lymphocele Following Liposuction in the Thigh. ( 28664307 )	Wang Q....Li P.	2017
30	Reply from Authors re: Jens Uwe Stolzenburg, Iason Kyriazis, Evangelos Liatsikos. Postoperative Lymphocele Formation after Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Should Not Be Considered an Inevitable Consequence of the Approach. Eur Urol 2017;71:159-60: Which Lymphatic Vessels Have To Be Secured During Pelvic Lymph Node Dissection for Prostate Cancer? ( 27666998 )	Mattei A....Di Pierro G.B.	2017
31	Lymphocele infection due to Peptoniphilus harei after radical prostatectomy. ( 29153289 )	Cobo F.	2017
32	Evaluation of sclerotherapy for the treatment of infected postoperative lymphocele. ( 28805604 )	Kim Y....Lee S.J.	2017
33	Lymphocele after Lipoma Removal in Inner Thigh. ( 28223756 )	Lee J.W....Seo S.H.	2017
34	A Breast Reconstruction Using a Breast Prosthesis and Capsular Flap for a Lymphocele Patient. ( 29184742 )	Yano T....Sawaizumi M.	2017
35	Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study. ( 28382800 )	Kim Y.H....Kim S.C.	2017
36	A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection. ( 29484065 )	Nishibeppu K....Otsuji E.	2017
37	Critical appraisal of consecutive 36 cases of post renal transplant lymphocele: a proposed algorithm. ( 28138768 )	Singh A.G....Desai M.R.	2017
38	Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients. ( 28822659 )	Salna M....Takeda K.	2017
39	Modern lymphatic dissection techniques for preventing post renal transplant lymphocele. ( 29151791 )	Lucan C.V....Buttice S.	2017
40	Prophylaxis of lymphocele formation after kidney transplantation via peritoneal fenestration: aA systematic review. ( 28295643 )	Mihaljevic A.L....Mehrabi A.	2017
41	Treatment of the Lymphocele After Kidney Transplantation: A Single-center Experience. ( 27496462 )	Bzoma B....Rutkowski B.	2016
42	Use of TachoSilAr to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study. ( 27046053 )	Minig L....Chuang L.	2016
43	Prevention and management of lymphocele formation following kidney transplantation. ( 28011070 )	Golriz M....Mehrabi A.	2016
44	Single-Session Endolymphatic Glue Embolization of Lymphocele after Heart Transplantation. ( 27287975 )	Chick J.F....Itkin M.	2016
45	Postoperative Lymphocele Formation after Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Should Not Be Considered an Inevitable Consequence of the Approach. ( 27595375 )	Stolzenburg J.U....Liatsikos E.	2016
46	Symptomatic Lymphocele Formation After Sentinel Lymph NodeA Biopsy for Early Stage Cervical Cancer. ( 26260297 )	Dogan N.U....Favero G.	2016
47	The incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissection. ( 26800257 )	Keskin M.S....RA+za Kural A.	2016
48	Evaluation of postoperative lymphocele according to amounts and symptoms by using 3-dimensional CT volumetry in kidney transplant recipients. ( 27617254 )	Jun H....Jung C.W.	2016
49	Massive Ascites in a Renal Transplant Patient after Laparoscopic Fenestration of a Lymphocele. ( 27891288 )	Kawaguchi S....Mizokami A.	2016
50	Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study. ( 27280398 )	ChAcreau E....Rouzier R.	2016

Sources

Genes for Lymphocele

Genes related to Lymphocele (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	KLK3	Kallikrein Related Peptidase 3	Protein Coding	15.98	DISEASES inferred ¹⁵
2	CABIN1	Calcineurin Binding Protein 1	Protein Coding	15.95	DISEASES inferred ¹⁵
3	MAPK8IP1	Mitogen-Activated Protein Kinase 8 Interacting Protein 1	Protein Coding	15.14	DISEASES inferred ¹⁵
4	MTOR	Mechanistic Target Of Rapamycin Kinase	Protein Coding	14.92	DISEASES inferred ¹⁵
5	ANKRD11	Ankyrin Repeat Domain 11	Protein Coding	14.75	DISEASES inferred ¹⁵
6	PCSK7	Proprotein Convertase Subtilisin/Kexin Type 7	Protein Coding	14.45	DISEASES inferred ¹⁵
7	RASA1	RAS P21 Protein Activator 1	Protein Coding	14.24	DISEASES inferred ¹⁵

Sources

Variations for Lymphocele

Sources

Expression for Lymphocele

Search GEO for disease gene expression data for Lymphocele.

Sources

Pathways for Lymphocele

Pathways related to Lymphocele according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	NFAT and Cardiac Hypertrophy ⁶⁵ Show member pathways IGF1R Signaling ⁶⁵ Signaling Involved in Cardiac Hypertrophy ⁶⁵	11.54	CABIN1 MTOR RASA1

Sources

GO Terms for Lymphocele

Biological processes related to Lymphocele according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	regulation of GTPase activity	GO:0043087	8.96	MTOR RASA1
2	multicellular organism growth	GO:0035264	8.62	ANKRD11 MTOR

Sources

Sources for Lymphocele

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia